Eculizumab as Salvage Treatment for Thrombotic Microangiopathy After Lung Transplantation
TMA after LT is infrequent but potentially devastating. Our findings suggest that short cycles of eculizumab may be effective for severe TMA after LT.
Authors
- Ana Huerta (ORCID: https://orcid.org/0000-0003-3342-7628)
- María Luisa Serrano Salazar (ORCID: https://orcid.org/0000-0002-6230-6377)
- Rodrigo Alonso (ORCID: https://orcid.org/0000-0002-7833-5084)
- Teresa Cavero (ORCID: https://orcid.org/0000-0001-5187-9906)
- Enrique Morales (ORCID: https://orcid.org/0000-0002-5824-6973)
- Hernando Trujillo (ORCID: https://orcid.org/0000-0002-3520-1422)
- Myriam Aguilar
Institutions
- Hospital Universitario 12 De Octubre (ES)
- Hospital Universitario Puerta de Hierro Majadahonda (ES)
Publication Details
- Journal
- Clinical Transplantation
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1111/ctr.15443
- Citations
- 1
- Primary Topic
- Complement system in diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.24